IPD fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
ImpediMed Ltd. engages in the development and distribution of bioimpedance devices with a focus on medical applications in the fluid status area. Its product SOZO, uses bioimpedance spectroscopy technology to measure and track critical information about the human body to aid clinicians in managing chronic disease and maximizing patient health. The company was founded by Melvyn John Bridges and Lucille Mayse Bridges on September 27, 1999 and is headquartered in Pinkenba, Australia.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
IPD does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company